Altre lingue Lavipharm S.A.

Azioni

Tempo differito Athens S.E. Altri mercati azionari 14:40:09 17/07/2024			Variaz. 5gg	Var. 1 gen.
0,9 ^EUR	-2,49%		-1,64%	+13,07%

28/02	Lavipharm S.A. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
2023	Lavipharm S.A. riporta i risultati degli utili per i nove mesi conclusi il 30 settembre 2023	CI

Lavipharm S A : PRESS RELEASE	09/07
Lavipharm S A : Announcement 5720/2024	09/07
Lavipharm S A : Announcement 4879/2024	17/06
Lavipharm S A : Annual Analysts Briefing	24/04
Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Lavipharm S A : ANNOUNCEMENT	11/12
Lavipharm S A : enters into a new asset purchase agreement	11/12
Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi.	11/12
Lavipharm S A : Asset Purchase Agreement for Lavipharm	01/12
Lavipharm S.A. signing of an asset purchase agreement to acquire Lonarid N and Lonalgal from Boehringer Ingelheim International GmbH.	01/12
Lavipharm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	08/11
Lavipharm S A : FINANCIAL RESULTS FIRST HALF OF 2023	21/09/23
Lavipharm S A : First Half 2023 Financial Results – Strong EBITDA increase	21/09/23
Lavipharm S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	21/09/23
Lavipharm S A : Annual Shareholders’ Meeting	06/07/23
Lavipharm S A : PRESS RELEASE SHAREHOLDERS MEETING	06/07/23
Lavipharm S.A.(ATSE:LAVI) added to ATHEX Composite Index	21/06/23
Lavipharm S A : Press Release Extraordinary Shareholders’ Meeting	26/05/23
Lavipharm S A : Results Q1 2023	04/05/23
Lavipharm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	04/05/23

Non ci sono risultati per questa ricerca